{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:13:14Z","timestamp":1785769994484,"version":"3.56.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1097\/01.psy.0000073870.93003.c4","type":"journal-article","created":{"date-parts":[[2003,7,25]],"date-time":"2003-07-25T12:20:16Z","timestamp":1059135616000},"page":"517-522","source":"Crossref","is-referenced-by-count":52,"title":["High Plasma Levels of N-Terminal Pro-Atrial Natriuretic Peptide Associated With Low Anxiety in Severe Heart Failure"],"prefix":"10.1097","volume":"65","author":[{"given":"Christoph","family":"Herrmann-Lingen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Klinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Schenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Beyermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Von Lewinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkert","family":"Pieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210213","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure.","volume":"341","author":"Schrier","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-7-20210213","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/01.CIR.88.3.1004","article-title":"Natriuretic peptide system in human heart failure.","volume":"88","author":"Wei","year":"1993","journal-title":"Circulation"},{"key":"R3-7-20210213","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1388-9842(01)00196-9","article-title":"Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists.","volume":"4","author":"Persson","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"R4-7-20210213","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1161\/01.CIR.81.6.1860","article-title":"Sympathoinhibitory effects of atrial natriuretic factor in normal humans.","volume":"81","author":"Floras","year":"1990","journal-title":"Circulation"},{"key":"R5-7-20210213","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005344-200001000-00017","article-title":"Sympathetic response to atrial natriuretic peptide in patients with congestive heart failure.","volume":"35","author":"Azevedo","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"R6-7-20210213","first-page":"5","article-title":"Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behavior.","volume":"108","author":"Wiedemann","year":"2000","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R7-7-20210213","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000127274","article-title":"Central and peripheral administration of atriopeptin is anxiolytic in rats.","volume":"65","author":"Strohle","year":"1997","journal-title":"Neuroendocrinology"},{"key":"R8-7-20210213","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archpsyc.58.4.371","article-title":"Anxiolytic-like effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.","volume":"58","author":"Wiedemann","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"R9-7-20210213","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0191-8869(97)00007-X","article-title":"The role of objective health indicators and neuroticism in perceived health and psychological well-being among patients with chronic heart failure.","volume":"22","author":"Murberg","year":"1997","journal-title":"Pers Individ Dif"},{"key":"R10-7-20210213","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale.","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"R11-7-20210213","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3999(96)00216-4","article-title":"International experiences with the Hospital Anxiety and Depression Scale- a review of validation data and clinical results.","volume":"42","author":"Herrmann","year":"1997","journal-title":"J Psychosom Res"},{"key":"R12-7-20210213","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the Hospital Anxiety and Depression Scale- an updated literature review.","volume":"52","author":"Bjelland","year":"2002","journal-title":"J Psychosom Res"},{"key":"R13-7-20210213","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0167-5273(87)90029-5","article-title":"A questionnaire to assess premonitory symptoms of myocardial infarction.","volume":"17","author":"Appels","year":"1987","journal-title":"Int J Cardiol"},{"key":"R14-7-20210213","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"R16-7-20210213","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00006842-200009000-00001","article-title":"Inflammation, depressive symptomatology, and coronary artery disease.","volume":"62","author":"Appels","year":"2000","journal-title":"Psychosom Med"},{"key":"R18-7-20210213","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/oxfordjournals.eurheartj.a015349","article-title":"Role of interactions between psychological and clinical factors in determining 6-month mortality among patients with acute myocardial infarction.","volume":"18","author":"Carinci","year":"1997","journal-title":"Eur Heart J"},{"key":"R19-7-20210213","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0022-3999(99)00086-0","article-title":"Effects of anxiety and depression on 5-year mortality in 5057 patients referred for exercise testing.","volume":"48","author":"Herrmann","year":"2000","journal-title":"J Psychosom Res"},{"key":"R20-7-20210213","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-3999(97)00202-X","article-title":"Autonomic balance revisited: panic anxiety and heart rate variability.","volume":"44","author":"Friedman","year":"1998","journal-title":"J Psychosom Res"},{"key":"R21-7-20210213","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/BF01796272","article-title":"Exercise induced increase of atrial natriuretic factor plasma concentrations and pulmonary pressure before and after coronary angioplasty.","volume":"68","author":"Scholz","year":"1990","journal-title":"Klin Wochenschr"},{"key":"R23-7-20210213","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0002-8703(98)70343-6","article-title":"Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.","volume":"135","author":"Muscholl","year":"1998","journal-title":"Am Heart J"},{"key":"R24-7-20210213","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1176\/appi.ajp.158.9.1514","article-title":"Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder.","volume":"158","author":"Strohle","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R25-7-20210213","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0002-9149(97)89176-X","article-title":"Comparison of atrial natriuretic peptide B-type natriuretic peptide and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.","volume":"77","author":"Davidson","year":"1996","journal-title":"Am J Cardiol"},{"key":"R26-7-20210213","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0002-9149(92)91196-B","article-title":"Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure.","volume":"70","author":"Elsner","year":"1992","journal-title":"Am J Cardiol"},{"key":"R27-7-20210213","first-page":"1531","article-title":"Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.","volume":"287","year":"2002","journal-title":"JAMA"}],"container-title":["Psychosomatic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006842-200307000-00029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:24:41Z","timestamp":1785767081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006842-200307000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.1097\/01.psy.0000073870.93003.c4","relation":{},"ISSN":["0033-3174"],"issn-type":[{"value":"0033-3174","type":"print"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}